廣東鴻圖(002101.SZ):非公開發行A股股票獲粵科集團批覆
格隆匯11月22日丨廣東鴻圖(002101.SZ)公佈,公司於近日收到廣東省粵科金融集團有限公司(簡稱“粵科集團”)作出的《廣東省粵科金融集團有限公司關於廣東鴻圖科技股份有限公司非公開發行A股股票的批覆》,粵科集團根據《上市公司國有股權監督管理辦法》(國資委、財政部、證監會令第36號)、《關於做好上市公司國有股權管理工作有關事項的通知》(粵國資函【2019】798號)的規定,原則同意公司本次非公開發行A股股票方案。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.